Global Skin Perfusion Pressure Testing Devices Market Size By Type (By Modality, Portable Device), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Skin Perfusion Pressure (SPP) Testing Devices Market was valued at USD 338 million in 2023 and is projected to reach USD 585 million by 2031, growing at a CAGR of 7.1% during the forecast period from 2023 to 2031. The market is gaining traction due to the increasing prevalence of peripheral artery disease (PAD) and chronic limb-threatening ischemia (CLTI), where SPP testing is critical in assessing wound healing potential and microcirculation. The demand for non-invasive and precise diagnostic tools in wound care, especially in diabetic patients, is a key factor fueling market growth.

Drivers

1. Rising Incidence of Vascular and Diabetic Conditions:

The increasing global burden of diabetes and related vascular complications is one of the primary drivers. Skin perfusion pressure devices are widely used for evaluating microvascular blood flow, especially in patients with diabetic foot ulcers and PAD.

2. Advancements in Non-Invasive Diagnostic Technology:

Technological innovations such as automated and digital SPP systems are enhancing diagnostic accuracy and patient comfort. These advancements reduce user dependency and deliver consistent results, which is boosting their adoption in clinical settings.

3. Growing Awareness in Wound Care Management:

The awareness surrounding the importance of early and accurate diagnosis of wound healing potential is rising, particularly among clinicians in dermatology, vascular surgery, and podiatry. This is promoting the use of SPP testing devices globally.

Restraints

1. High Equipment Cost and Limited Accessibility:

The relatively high cost of SPP devices may limit their adoption in smaller healthcare facilities and in low-income countries. Additionally, lack of skilled personnel to operate these devices could impede market growth.

2. Reimbursement Challenges:

In several regions, limited reimbursement policies for SPP testing procedures can hinder widespread clinical implementation, especially in outpatient or home healthcare settings.

Opportunity

1. Expansion of Home-Based and Point-of-Care Testing:

The shift towards decentralized healthcare is opening opportunities for compact and user-friendly SPP devices suitable for home care and remote diagnostics.

2. Integration with Digital Health Platforms:

Opportunities lie in integrating SPP devices with telemedicine and digital health records to enable remote monitoring and real-time data sharing for chronic wound management.

Market by System Type Insights

The market is segmented by system type into manual and automated skin perfusion pressure testing devices. Automated systems held the largest share in 2023 due to their precision, ease of use, and minimal operator dependency. These systems are increasingly being adopted in hospitals and specialty clinics for consistent and repeatable results, making them the preferred choice over manual devices.

Market by End-use Insights

Hospitals were the leading end-users in 2023, accounting for over 45% of the market share. These facilities house multidisciplinary wound care centers that frequently utilize SPP testing for vascular assessment. However, the Home Healthcare segment is poised for the fastest growth during the forecast period, driven by the rising preference for home-based chronic disease management.

Market by Regional Insights

North America dominated the market in 2023, supported by advanced healthcare infrastructure, higher prevalence of diabetes and PAD, and greater adoption of non-invasive diagnostic devices. Europe follows closely due to strong reimbursement frameworks and robust clinical research activities. Asia-Pacific is expected to experience the highest CAGR, fueled by improving healthcare access, large diabetic populations, and expanding awareness in emerging economies.

Competitive Scenario

Leading players in the Global Skin Perfusion Pressure Testing Devices Market include Moor Instruments Ltd., Vasamed Inc., Perimed AB, Medtronic plc, Biopac Systems Inc., and Koven Technology Inc. Key strategies among these players include continuous product innovation, strategic partnerships with wound care centers, and expansion into untapped emerging markets.

Scope of Work – Global Skin Perfusion Pressure Testing Devices Market

Report Metric Details

Market Size (2023) USD 338 million

Projected Market Size (2031) USD 585 million

CAGR (2023–2031) 7.1%

Market Segments By System Type (Manual, Automated), End-use (Hospitals, Specialty Clinics, Home Healthcare), Region

Growth Drivers Rising diabetic and vascular disease prevalence, non-invasive diagnostic advancements

Opportunities Home-based care growth, telemedicine integration

Key Market Developments

2023: Moor Instruments launched an updated SPP analyzer with enhanced sensor precision and Bluetooth connectivity for wireless data transmission to healthcare systems.

2024: Vasamed Inc. partnered with a U.S.-based telehealth provider to integrate SPP monitoring into home-based wound care programs.

2025: Perimed AB expanded its market reach into Southeast Asia through distributor collaborations, addressing the region’s growing diabetic population.

FAQs

1. What is the current market size of the Global Skin Perfusion Pressure Testing Devices Market?

The market was valued at USD 338 million in 2023.

2. What is the major growth driver of the Global Skin Perfusion Pressure Testing Devices Market?

The increasing prevalence of diabetes and PAD, leading to greater adoption of SPP testing for wound care assessment.

3. Which is the largest region during the forecast period in the Global Skin Perfusion Pressure Testing Devices Market?

North America held the largest share in 2023, while Asia-Pacific is expected to grow the fastest.

4. Which segment accounted for the largest market share in the Global Skin Perfusion Pressure Testing Devices Market?

The Automated